Komori
Presentation materials for financial results4275Carlit Co.,Ltd.Materials and Chemicals

Notice of presentation materials for the fiscal year ending March 2026 results briefing

For the fiscal year ended March 2026, revenue decreased 1.8% year on year, while operating profit increased 13.5% and net income increased 15.8%. For the fiscal year ending March 2027, revenue is expected to increase, but operating profit and ordinary profit are forecast to fall below the previous fiscal year's results.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
412
¥ million
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFiscal year ending March 20269 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥36,247 million-1.8%
Operating profit¥3,459 million+13.5%
Ordinary income¥3,755 million+13.1%
Net income¥2,976 million+15.8%
Selling, general and administrative expenses¥6,073 million
Full-year earnings forecast
Net Sales
¥37,200 million
Operating profit
¥3,200 million
Ordinary income
¥3,300 million
Net income
¥3,000 million
Year-end dividend
¥42 per share
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Operating profit for the fiscal year ended March 2025¥3.04 billion
  • Change in operating profit+¥0.4 billion
  • Operating profit, fiscal year ended March 2026¥3.45 billion
New initiatives
  • Capital investment to increase ammonium perchlorate production
  • Investment in manufacturing facilities for solid propellants for defense applications (¥7 billion, scheduled for completion in fiscal 2027)
  • Upgrade the PET line from the hot-fill method to the aseptic method
  • Research and development and mass production of solid propellants, and business expansion into related areas
  • Additional business development investment focused on priority areas
Key KPIsA metric the company considers important as a management benchmark.
  • Employee Engagement63.5 %
  • PBR1.42 times
    Year on year against the same period last yearImproved from 0.66x
  • ROE7.7 %
    Year on year against the same period last yearImproved from 6.9%
Segment results
  • Chemicals
    Net Sales¥21,977 million (YoY -2.0%)
    Operating profit¥1,858 million (YoY +25.7%)
  • Bottling
    Net Sales¥4,480 million (YoY -1.0%)
    Operating profit¥378 million (YoY +9.6%)
  • Metal Processing
    Net Sales¥7,303 million (YoY +1.0%)
    Operating profit¥602 million (YoY +18.5%)
  • Engineering Services
    Net Sales¥5,251 million (YoY +19.0%)
    Operating profit¥795 million (YoY -3.3%)
Medium-term management plan targets
  • TargetOperating profit
    Target value¥4.2 billion
    Target fiscal yearFY2027
  • TargetPBR
    Target value2x or more
    Target fiscal yearFiscal year ending March 2028
  • TargetROE
    Target value8.5%
    Target fiscal yearFiscal year ending March 2028
  • TargetEmployee Engagement
    Target value6.5 percentage-point increase from the fiscal 2025 actual of 63.5%
    Target fiscal yearFY2027
Financial targets
  • ROE
    Target value8.5%
    Actual value7.7%
  • PBR
    Target value2x or more
    Actual value1.42x
Capital expenditures
210 Hundreds of millions of yen
Annual Dividend
Annual dividend per share¥42 per share
End of period¥42 per share
Acquisition of treasury shares
Buyback limit¥1 billion
PeriodMay 2026
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredFiscal year ending March 2026
Net Sales¥36,247 million (YoY -1.8%)
Operating profit¥3,459 million (YoY +13.5%)
Ordinary income¥3,755 million (YoY +13.1%)
Net income¥2,976 million (YoY +15.8%)
Selling, general and administrative expenses¥6,073 million
Full-year earnings forecastNet Sales ¥37,200 million / Operating profit ¥3,200 million / Ordinary income ¥3,300 million / Net income ¥3,000 million / Year-end dividend ¥42 per share
Segment resultsSegment Chemicals / Net Sales ¥21,977 million (YoY -2.0%) / Operating profit ¥1,858 million (YoY +25.7%), Segment Bottling / Net Sales ¥4,480 million (YoY -1.0%) / Operating profit ¥378 million (YoY +9.6%), Segment Metal Processing / Net Sales ¥7,303 million (YoY +1.0%) / Operating profit ¥602 million (YoY +18.5%), Segment Engineering Services / Net Sales ¥5,251 million (YoY +19.0%) / Operating profit ¥795 million (YoY -3.3%)
Breakdown of Factors Affecting the ChangeFactors Operating profit for the fiscal year ended March 2025 / Amount ¥3.04 billion, Factors Change in operating profit / Amount +¥0.4 billion, Factors Operating profit, fiscal year ended March 2026 / Amount ¥3.45 billion
Key KPIsIndicator name Employee Engagement / Value 63.5 % / Year on year against the same period last year Not disclosed, Indicator name PBR / Value 1.42 times / Year on year against the same period last year Improved from 0.66x, Indicator name ROE / Value 7.7 % / Year on year against the same period last year Improved from 6.9%
Medium-term management plan targetsTarget Operating profit / Target value ¥4.2 billion / Target fiscal year FY2027, Target PBR / Target value 2x or more / Target fiscal year Fiscal year ending March 2028, Target ROE / Target value 8.5% / Target fiscal year Fiscal year ending March 2028, Target Employee Engagement / Target value 6.5 percentage-point increase from the fiscal 2025 actual of 63.5% / Target fiscal year FY2027
Financial targetsIndicator ROE / Target value 8.5% / Actual value 7.7%, Indicator PBR / Target value 2x or more / Actual value 1.42x
Annual DividendAnnual dividend per share ¥42 per share / Interim Not disclosed / End of period ¥42 per share
Acquisition of treasury sharesBuyback limit ¥1 billion / Period May 2026
Capital expenditures210 Hundreds of millions of yen
New initiativesCapital investment to increase ammonium perchlorate production, Investment in manufacturing facilities for solid propellants for defense applications (¥7 billion, scheduled for completion in fiscal 2027), Upgrade the PET line from the hot-fill method to the aseptic method, Research and development and mass production of solid propellants, and business expansion into related areas, Additional business development investment focused on priority areas
Items this document does not state (14)
Gross Profit MarginOperating profit marginResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookPayout ratioOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the fiscal year ended March 2026, reflecting appropriate prices in sales companies, cost reductions and productivity improvements contributed to higher profit. On the other hand, sales of certain products and in some areas declined due to slower EV demand, adjustments by certain customers, and lower demand from the paper and pulp, automotive and steel industries. For the fiscal year ending March 2027, the company expects production capacity to be constrained by the renewal of bottling equipment, uncertainty and higher costs in procuring raw materials and fuel due to the situation in the Middle East, and intensifying competition in engineering services.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of presentation materials for the fiscal year ending March 2026 results briefing | Carlit Co.,Ltd. (4275) timely disclosure | Komori